Thrombus Length Estimation on Delayed Gadolinium-Enhanced T1

Stroke. 2016 Mar;47(3):756-61. doi: 10.1161/STROKEAHA.115.011401. Epub 2016 Jan 14.

Abstract

Background and purpose: Previous studies revealed a close relationship between thrombus length and recanalization rate after intravenous thrombolysis (IVT). As a novel approach, we prospectively adjusted the order of sequence acquisition to obtain delayed gadolinium-enhanced T1 (dGE-T1) and thereby assess thrombus length on dGE-T1 to evaluate its predictive value for recanalization after IVT.

Methods: We reviewed prospectively collected clinical and imaging data from acute ischemic stroke patients with middle cerebral artery occlusion who underwent multimodal magnetic resonance imaging before and 24 hours after IVT. Perfusion-weighted imaging was performed followed by conventional T1. We measured thrombus length on dGE-T1 and examined its association with middle cerebral artery recanalization.

Results: Of the included 74 patients, the median age was 66 years and 28 (37.8%) were women. Thrombus length was 8.18±4.56 mm on dGE-T1, which was an acceptable predictor for no recanalization (odds ratio, 1.196; 95% confidence interval, 1.015-1.409; P=0.033), with a receiver-operator characteristic of 0.732 (95% confidence interval, 0.619-0.845; P=0.001). The optimal cut-off point was identified at 6.77 mm, which yielded a sensitivity of 77.8%, a specificity of 57.9%, and an odds ratio of 4.81 (95% confidence interval, 1.742-13.292; P=0.002). Moreover, no one achieved recanalization after IVT when length of thrombus exceeded 14 mm on dGE-T1.

Conclusions: The dGE-T1, obtained by simply adjusting scanning order in multimodal magnetic resonance imaging protocol, is a useful tool for thrombus length estimation and middle cerebral artery recanalization prediction after IVT.

Keywords: artifact; magnetic resonance imaging; middle cerebral artery; stroke; thrombolytic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Follow-Up Studies
  • Gadolinium* / administration & dosage
  • Humans
  • Magnetic Resonance Angiography / methods*
  • Male
  • Middle Aged
  • Prospective Studies
  • Radiography
  • Retrospective Studies
  • Thrombolytic Therapy / methods
  • Thrombosis / diagnostic imaging*
  • Thrombosis / drug therapy
  • Time Factors

Substances

  • Fibrinolytic Agents
  • Gadolinium